147 related articles for article (PubMed ID: 32490148)
1. Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Yin YJ; Chen YC; Xu L; Zhao XH; Song Yang
Int J Cardiol Heart Vasc; 2020 Jun; 28():100541. PubMed ID: 32490148
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
[TBL] [Abstract][Full Text] [Related]
3. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Lipoprotein-Associated Phospholipase A
Yang L; Wang H; Zhang Y; Han T; Wang W
Clin Appl Thromb Hemost; 2018 Jul; 24(5):822-827. PubMed ID: 29121808
[TBL] [Abstract][Full Text] [Related]
5. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
Buturak A; Degirmencioglu A; Erturk M; Karakurt H; Demir AR; Surgit O; Pusuroglu H; Akgul O; Serteser M; Norgaz T; Gorgulu S
Coron Artery Dis; 2015 Jun; 26(4):333-40. PubMed ID: 25714068
[TBL] [Abstract][Full Text] [Related]
6. Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
Huang Z; Shui X; Ling Y; Zhou L; Shi W; Luo Y; Li S; Zhu J; Yu S; Liu J
Clin Cardiol; 2020 Dec; 44(2):176-85. PubMed ID: 33289114
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum miR-133a predicts patients at risk of periprocedural myocardial injury after elective percutaneous coronary intervention.
Zhou Y; Chen Z; Chen A; Ma J; Qian J; Ge J
Cardiol J; 2022; 29(2):284-292. PubMed ID: 32207842
[TBL] [Abstract][Full Text] [Related]
8. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
9. Association of serum laboratory parameters with periprocedural myocardial infarction after a primary percutaneous coronary intervention.
Deng Q; Hou J; Deng X; Zhong Z
Perfusion; 2023 Mar; 38(2):393-400. PubMed ID: 35038275
[TBL] [Abstract][Full Text] [Related]
10. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
[TBL] [Abstract][Full Text] [Related]
11. Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.
Zhang L; Li Z; Li N
Emerg Med Int; 2022; 2022():1698315. PubMed ID: 35726302
[TBL] [Abstract][Full Text] [Related]
12. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
Harada K; Kikuchi R; Suzuki S; Tanaka A; Aoki T; Iwakawa N; Kojima H; Hirayama K; Mitsuda T; Sumi T; Negishi Y; Ishii H; Murohara T
Lipids Health Dis; 2018 Feb; 17(1):21. PubMed ID: 29391013
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention.
Hosoda H; Asaumi Y; Noguchi T; Morita Y; Kataoka Y; Otsuka F; Nakao K; Fujino M; Nagai T; Nakai M; Nishimura K; Kono A; Komori Y; Hoshi T; Sato A; Kawasaki T; Izumi C; Kusano K; Fukuda T; Yasuda S
J Cardiovasc Magn Reson; 2020 Jan; 22(1):5. PubMed ID: 31941517
[TBL] [Abstract][Full Text] [Related]
14. The benefit of exercise rehabilitation guided by 6-minute walk test on lipoprotein-associated phospholipase A2 in patients with coronary heart disease undergoing percutaneous coronary intervention: a prospective randomized controlled study.
Liu X; Zhou W; Fan W; Li A; Pang J; Chen Z; Li X; Hu X; Zeng Y; Tang L
BMC Cardiovasc Disord; 2022 Apr; 22(1):177. PubMed ID: 35430800
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acids as a marker for predicting periprocedural myocardial injury after coronary intervention.
Wang Y; Zhang HW; Guo YL; Zhu CG; Wu NQ; Li JJ
Postgrad Med J; 2019 Jan; 95(1119):18-22. PubMed ID: 30700582
[TBL] [Abstract][Full Text] [Related]
16. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.
Prasad A; Rihal CS; Lennon RJ; Singh M; Jaffe AS; Holmes DR
Circ Cardiovasc Interv; 2008 Aug; 1(1):10-9. PubMed ID: 20031650
[TBL] [Abstract][Full Text] [Related]
17. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
J Clin Lipidol; 2014; 8(4):423-32. PubMed ID: 25110224
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.
Koskinas KC; Ndrepepa G; Räber L; Karagiannis A; Kufner S; Zanchin T; Hieber J; Hunziker L; Mayer K; Byrne RA; Heg D; Windecker S; Kastrati A
Circ Cardiovasc Interv; 2018 Dec; 11(12):e006752. PubMed ID: 30545257
[TBL] [Abstract][Full Text] [Related]
19. [Value of index of microcirculatory resistance for early prediction of periprocedural myocardial microcirculatory injury after percutaneous coronary intervention in patients with coronary heart disease].
You W; Yang ZJ; Ye F
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):894-900. PubMed ID: 31744279
[No Abstract] [Full Text] [Related]
20. Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis.
Verdoia M; Rolla R; Gioscia R; Rognoni A; De Luca G;
J Thromb Thrombolysis; 2023 Jul; 56(1):37-44. PubMed ID: 37022507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
